Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03906526
Title A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294-3300 United States Details
Boston University Boston Massachusetts 02215 United States Details
Washington University Saint Louis Missouri 63110 United States Details
University of Cincinnati Cincinnati Ohio 45267-0501 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Pittsburgh Medical Center Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Sanford Cancer Center Sioux Falls South Dakota 57104-8805 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field